Literature DB >> 6359516

Cyclocryotherapy for glaucoma. Evaluation of techniques.

M Prost.   

Abstract

Clinical results of cyclocryotherapy reported by various authors have been contradictory. This is partly due to considerable differences in technique. In this paper, details of the technique of cyclocryotherapy are reviewed in order to determine the most effective protocol of treatment. Parameters such as temperature, duration, probe placement, diameter of the tip, pressure exerted on sclera, extent of ciliary body freezing, additional cyclocryotherapy and preparation of patient for treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359516     DOI: 10.1016/0039-6257(83)90077-2

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  6 in total

1.  Transscleral Nd: YAG laser cyclophotocoagulation versus cyclocryotherapy.

Authors:  Y Suzuki; M Araie; A Yumita; T Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Cyclocryotherapy: a review of cases over a 10-year period.

Authors:  M T Benson; M E Nelson
Journal:  Br J Ophthalmol       Date:  1990-02       Impact factor: 4.638

3.  Telerobotic contact transscleral cyclophotocoagulation of the ciliary body with the diode laser.

Authors:  David A Belyea; Michael J Mines; Wen-Jeng Yao; Jacob A Dan; Kraig S Bower
Journal:  J Robot Surg       Date:  2013-07-26

4.  Microwave cyclodestruction: evaluation on human eyes.

Authors:  P T Finger; H D Perry; J L Shakin; D R Bisciotti; R J Nattis
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

5.  Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patients.

Authors:  Byoung Seon Kim; Young Jun Kim; Seong Wook Seo; Ji Myong Yoo; Seong Jae Kim
Journal:  Korean J Ophthalmol       Date:  2015-01-22

6.  Current surgical options for the management of pediatric glaucoma.

Authors:  Jose Morales; Sami Al Shahwan; Sami Al Odhayb; Ibrahim Al Jadaan; Deepak P Edward
Journal:  J Ophthalmol       Date:  2013-04-24       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.